The invention provides the use of an attenuated human rotavirus strain from a G1 serotype in the preparation of a composition for inducing an immune response against rotavirus infection from the G1 and the non-G1 rotavirus serotypes selected from the group consisting of: G2, G3, G4 and G9 serotypes.